"The Pharm House," Mr. Powers' title, was an awarded Finalist in the 2014 National Indie Excellence Awards. The NIEA stated, "The Pharm House truly embodies the excellence that this award was created to celebrate. We salute you and your fine work."
This suspense / thriller novel is set in today’s international pharmaceutical industry. "The Pharm House" features protagonist, Nick Harding, who is struggling to raise a young daughter as a single parent. He stumbles across a global plot to take over the pharmaceutical company where he works. Mysterious deaths occur, including Nick’s mentor. Nick’s career, family and life are threatened. Nick is kind of like Alan Gregory in the Stephen White stories, just a guy trying to get through life and take of his family, but things (bad people) keep getting in the way.
This intriquing title is steadily growing to best-seller status. To get your copy early for the event at C3 contact DonnaInk Publications, L.L.C. (www.donnaink.org). For bulk orders, signings and/or interviews write to special_markets@
About the Author: Bill Powers worked in pharmaceutical R&D (Johnson & Johnson) for 26 years, rising to the position of Vice President of Global Preclinical Development. In various management roles, he led groups of scientists in the US, Europe and Asia; he administered multi-million dollar budgets and was instrumental in the successful development of several marketed pharmaceutical products. With a Ph.D. in Toxicology, Bill is a Diplomat of the American Board of Toxicology. He has published numerous abstracts, articles and book chapters on various topics in toxicology. He has traveled extensively in the US, Europe and Asia, leading research groups in Belgium and Mumbai, India. Bill is married, has one adult child and one brother. Bill’s love of words and books started in childhood, stimulated by parents who were both teachers. A voracious reader, he enjoys both fiction (R. Pearson, S. White, J. Patterson, H. Coben, D. Baldacci, S. Berry, etc.) and biographies (Lincoln, Grant, T. Roosevelt, J.P. Morgan, etc.). Now that he has moved away from his industrial career, he plans to aggressively pursue his passion of becoming a published author.